A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase–mediated Recovery of IFN-γ–induced Intestinal Epithelial Barrier Defects

(2016) Moorthy Krishnan et al.   INFLAMMATORY BOWEL DISEASES

Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

(2014) Radha K. Dhiman et al.   GASTROENTEROLOGY

Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial

(2014) Hemalatha Rajkumar et al.   MEDIATORS OF INFLAMMATION

VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

(2012) Andrea Mencarelli et al.   PLoS One

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

(2010) Anne Sofie Andreasen et al.   BRITISH JOURNAL OF NUTRITION

Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome

(2010) Diego Lucero et al.   CLINICA CHIMICA ACTA

The role of the gut microbiota in nonalcoholic fatty liver disease

(2010) Ahmed Abu-Shanab et al.   Nature Reviews Gastroenterology & Hepatology

B-Mode Ultrasound With Algorithm Based on Statistical Analysis of Signals: Evaluation of Liver Fibrosis in Patients With Chronic Hepatitis C

(2009) Hidenori Toyoda et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: The CUPRAC–BCS assay

(2009) Carlos Campos et al.   ANALYTICAL BIOCHEMISTRY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

(2009) Cecilia Söderberg et al.   HEPATOLOGY

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

(2009) Sergio Peralta et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study

(2008) R. S. Elkeles et al.   EUROPEAN HEART JOURNAL

Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults

(2008) Riina A Kekkonen et al.   WORLD JOURNAL OF GASTROENTEROLOGY